High Fractions of CD34+CD38-Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Marie Toft-Petersen, Line Nederby, Peter Hokland, Anne Stidsholt Roug

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalBlood
Volume124
Issue number21
ISSN0006-4971
Publication statusPublished - 2014
EventASH Annual Meeting - San Francisco, United States
Duration: 6 Dec 20149 Dec 2014
Conference number: 56th

Conference

ConferenceASH Annual Meeting
Number56th
Country/TerritoryUnited States
CitySan Francisco
Period06/12/201409/12/2014

Cite this